General Information
MAP Migraine 301
A Randomized, Double Blind, Placebo Controlled, Parallel Group Study of MAP0004 (Tempo DHE) in Adult Migraineurs for a Single Migraine Followed by Open –Label Extensions to 26/52 Weeks”
| Protocol | MAP0004-Cl-P301 |
|---|---|
| Identifier | MAP0004-Cl-P301 |
| UID | 0304541a-ab81-465e-bac3-cd1efe0131a7 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Migraine / Adult |
| Launch Year | 2009 |
| NCT Number | - |
| Created | 2010-05-21 16:00 |
| Last Updated | 2010-05-21 16:00 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2008-12-02 | No |
| Enrollment Open | 2008-07-28 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2010-11-04 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | - | No | |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | MAP Pharmaceuticals, Inc. |
|---|---|
| Division | MAP Pharmaceuticals, Inc. |
| Team | MAP Pharmaceuticals, Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
